Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to 0.31%.

  • Agios Pharmaceuticals' Return on Assets fell 7000.0% to 0.31% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.31%, marking a year-over-year decrease of 7000.0%. This contributed to the annual value of 0.28% for FY2025, which is 8000.0% down from last year.
  • As of Q4 2025, Agios Pharmaceuticals' Return on Assets stood at 0.31%, which was down 7000.0% from 0.28% recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Assets peaked at 1.32% during Q4 2021, and registered a low of 0.45% during Q2 2024.
  • For the 5-year period, Agios Pharmaceuticals' Return on Assets averaged around 0.21%, with its median value being 0.0% (2022).
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Assets skyrocketed by 14800bps in 2021, and later plummeted by -11500bps in 2022.
  • Agios Pharmaceuticals' Return on Assets (Quarter) stood at 1.32% in 2021, then plummeted by -100bps to 0.0% in 2022, then tumbled by -11332bps to 0.37% in 2023, then soared by 206bps to 0.39% in 2024, then tumbled by -180bps to 0.31% in 2025.
  • Its last three reported values are 0.31% in Q4 2025, 0.28% for Q3 2025, and 0.43% during Q2 2025.